(Q79272921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Increased expression of heparanase in overt diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

van den Hoven MJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Rops AL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bakker MA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Aten J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Rutjes N

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Roestenberg P

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Goldschmeding R

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Zcharia E

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Vlodavsky I

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Berden JH

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

18 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

2100-2108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001985

20 December 2019

exact match

0 references

cites work

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase expression during normal liver development and following partial hepatectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparan sulfate proteoglycans in glomerular inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Molecular properties and involvement of heparanase in cancer progression and normal development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

An ELISA method for the detection and quantification of human heparanase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Increased expression of heparanase in puromycin aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Isolation and characterization of conditionally immortalized mouse glomerular endothelial cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Urinary glycosaminoglycan excretion and microalbuminuria in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

The Urinary Excretion of Heparan Sulfate by Juvenile- and Adult-Onset Diabetic Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Structure and biological activity of heparinoid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase as a molecular target of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Anti-GBM nephritis in the mouse: severe proteinuria in the heterologous phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Heparanase as mediator of angiogenesis: mode of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001985

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17051139%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 December 2019

0 references

1 reference